The earnings call reflects strong growth in membership and revenue, driven by innovation and operational efficiency. Despite some concerns about cash flow due to debt repayment and reliance on the GLP-1 market segment, the overall financial and strategic outlook remains positive.

Company Guidance

During Omada Health's third-quarter 2025 earnings call, several key metrics highlighted the company's strong performance and strategic initiatives. Membership increased by 53% year-over-year, reaching 831,000 members, while revenue grew by 49% to $68 million. The company achieved a GAAP gross margin of 66% and a non-GAAP gross margin of 68%, both showing significant improvement from the previous year. Additionally, Omada narrowed its net loss to $3 million from $9 million in the third quarter of 2024 and recorded its first positive adjusted EBITDA of $2 million, compared to a $5 million loss in the prior year. Omada also announced strategic investments in GLP-1 prescribing and AI-driven innovations to enhance care and operational efficiency. Looking forward, Omada expects 2025 revenue to range between $251.5 million and $254.5 million, with an adjusted EBITDA between negative $2 million and breakeven, reflecting confidence in its scalable and integrated multi-condition platform.

Significant Member Growth

Total members climbed 53% year-over-year to 831,000, including 79,000 net new members during the quarter.

Revenue and Financial Improvements

Revenue grew 49% year-over-year to $68 million. GAAP gross margin reached 66% with non-GAAP at 68%. Net loss reduced to $3 million from $9 million in Q3 '24. First positive adjusted EBITDA of $2 million compared to a $5 million loss last year.

Product and Innovation Milestones

Announced prescribing for anti-obesity medications within GLP-1 Care Track. Introduced AI-driven Meal Map and OmadaSpark, enhancing member engagement and nutrition feedback.

Operational Efficiency

Operating expenses rose only 24% and cost of revenue 31%, while revenue is up 51% year-to-date, showcasing strong operational leverage.

Research and Clinical Outcomes

Published 30th peer-reviewed publication. Demonstrated significant savings and clinical outcomes in joint and muscle health and weight management programs.

Omada Health, Inc. (OMDA) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

OMDA Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Aug 06, 2026	2026 (Q2)	- / -	-0.24	―	―	―
Nov 06, 2025	2025 (Q3)	-0.08 / -0.06	-0.166	63.86% (+0.11)
Aug 07, 2025	2025 (Q2)	-0.12 / -0.24	-0.192	-25.00% (-0.05)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

OMDA Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Nov 06, 2025	$21.87	$20.31	-7.13%
Aug 07, 2025	$19.46	$19.02	-2.26%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Omada Health, Inc. (OMDA) report earnings?

Omada Health, Inc. (OMDA) is schdueled to report earning on Aug 06, 2026, After Close (Confirmed).

What is Omada Health, Inc. (OMDA) earnings time?

Omada Health, Inc. (OMDA) earnings time is at Aug 06, 2026, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is OMDA EPS forecast?

Currently, no data Available

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing